Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
Mutations in the KRAS gene are associated with poor response to epidermal growth factor receptor inhibitors used in the treatment of metastatic colorectal cancer. Factors influencing KRAS test results in tumor sp...